Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Dr. Joel Warsh

πŸ‘€ Speaker
798 total appearances

Appearances Over Time

Podcast Appearances

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

It doesn't make any sense. You never say that in science. You're always looking forward. And the science is definitely not settled on any of these topics. I mean, there's no way that you could say that going through it at this point. I have no reason to say anything other than I'm not against vaccines. But there are so many aspects of the science that it's just not settled on.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

It doesn't make any sense. You never say that in science. You're always looking forward. And the science is definitely not settled on any of these topics. I mean, there's no way that you could say that going through it at this point. I have no reason to say anything other than I'm not against vaccines. But there are so many aspects of the science that it's just not settled on.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

And the foundation of a lot of this research is quite flawed and not great. And you go back to the research on some of these original vaccines like DTP and polio. Those studies were not done in the way we do studies today. And so you're basing the safety profile on some of the things that we used to do. We didn't have randomized controlled trials back then.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

And the foundation of a lot of this research is quite flawed and not great. And you go back to the research on some of these original vaccines like DTP and polio. Those studies were not done in the way we do studies today. And so you're basing the safety profile on some of the things that we used to do. We didn't have randomized controlled trials back then.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

And the foundation of a lot of this research is quite flawed and not great. And you go back to the research on some of these original vaccines like DTP and polio. Those studies were not done in the way we do studies today. And so you're basing the safety profile on some of the things that we used to do. We didn't have randomized controlled trials back then.

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

So other than the polio, the polio, the original one, which was an amazing study. So it wasn't quite to the degree of the things that we do today, but it was like 2 million people in that original polio study because people were really invested. Can you imagine if we had studies today that had 2 million people in them? That is the kind of research that we should require to give

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

So other than the polio, the polio, the original one, which was an amazing study. So it wasn't quite to the degree of the things that we do today, but it was like 2 million people in that original polio study because people were really invested. Can you imagine if we had studies today that had 2 million people in them? That is the kind of research that we should require to give

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

So other than the polio, the polio, the original one, which was an amazing study. So it wasn't quite to the degree of the things that we do today, but it was like 2 million people in that original polio study because people were really invested. Can you imagine if we had studies today that had 2 million people in them? That is the kind of research that we should require to give

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

a new vaccine to our kids, especially to a baby. You know, we have hepatitis B vaccine on the market that the original studies in the package insert say the safety was studied for four or five days. And there are all sorts of, you know, requests to look where is the other research? Where is the data that it's safe?

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

a new vaccine to our kids, especially to a baby. You know, we have hepatitis B vaccine on the market that the original studies in the package insert say the safety was studied for four or five days. And there are all sorts of, you know, requests to look where is the other research? Where is the data that it's safe?

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

a new vaccine to our kids, especially to a baby. You know, we have hepatitis B vaccine on the market that the original studies in the package insert say the safety was studied for four or five days. And there are all sorts of, you know, requests to look where is the other research? Where is the data that it's safe?

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

How can we give something to babies that we don't have the most strict evidence that it's safe and the most benefit? That's why, again, some people question the vaccine program because they say giving hepatitis B to a one day old baby, it doesn't make sense to me. So why are we doing this?

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

How can we give something to babies that we don't have the most strict evidence that it's safe and the most benefit? That's why, again, some people question the vaccine program because they say giving hepatitis B to a one day old baby, it doesn't make sense to me. So why are we doing this?

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

How can we give something to babies that we don't have the most strict evidence that it's safe and the most benefit? That's why, again, some people question the vaccine program because they say giving hepatitis B to a one day old baby, it doesn't make sense to me. So why are we doing this?

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

Most countries don't mandate it, certainly in the first couple of days. I understand. I mean, it certainly has worked. The program to give vaccines for hepatitis B has decreased the risk of hepatitis B. You're basically making the notion that vaccines don't have any potential...

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

Most countries don't mandate it, certainly in the first couple of days. I understand. I mean, it certainly has worked. The program to give vaccines for hepatitis B has decreased the risk of hepatitis B. You're basically making the notion that vaccines don't have any potential...

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

Most countries don't mandate it, certainly in the first couple of days. I understand. I mean, it certainly has worked. The program to give vaccines for hepatitis B has decreased the risk of hepatitis B. You're basically making the notion that vaccines don't have any potential...

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

harm or issue when you're giving to one day old baby and we have to be reasonable now we're doing a hepatitis b a vitamin k and an rsv essentially in those first couple of days there has to be a point where you say how many things you want to give to a newborn baby that is one day old okay let's look at hepatitis b do we truly need to give that to a one day old baby or if the parents been tested if they don't have hepatitis b

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

harm or issue when you're giving to one day old baby and we have to be reasonable now we're doing a hepatitis b a vitamin k and an rsv essentially in those first couple of days there has to be a point where you say how many things you want to give to a newborn baby that is one day old okay let's look at hepatitis b do we truly need to give that to a one day old baby or if the parents been tested if they don't have hepatitis b

The Dr. Hyman Show
Why Vaccine Safety Is So Hard to Talk About β€” with Dr. Joel Warsh

harm or issue when you're giving to one day old baby and we have to be reasonable now we're doing a hepatitis b a vitamin k and an rsv essentially in those first couple of days there has to be a point where you say how many things you want to give to a newborn baby that is one day old okay let's look at hepatitis b do we truly need to give that to a one day old baby or if the parents been tested if they don't have hepatitis b